Gregory Bailey, Director at Biohaven Ltd. (BHVN), bought 400,000 shares at $7.50 ($3.0M) on 2025-11-13, disclosed to the SEC on 2025-11-17.
Open-market purchase of $3.0M BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |
| SER | BUY | 2024-08-22 | $15K | — | Filing → |